Works matching IS 0195668X AND DT 2022 AND VI 43 AND IP 41
Results: 23
Sodium–glucose co-transporter 2 inhibition: the saga continues.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4215, doi. 10.1093/eurheartj/ehac590
- By:
- Publication type:
- Article
Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4227, doi. 10.1093/eurheartj/ehac502
- By:
- Publication type:
- Article
Pulmonary artery aneurysm and dissection caused by patent ductus arteriosus.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4441, doi. 10.1093/eurheartj/ehac438
- By:
- Publication type:
- Article
Influenza vaccine in cardiovascular disease: time to move the needle.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4389, doi. 10.1093/eurheartj/ehac491
- By:
- Publication type:
- Article
Economic value of multimodal cardiovascular screening.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4403, doi. 10.1093/eurheartj/ehac489
- By:
- Publication type:
- Article
Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS).
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4392, doi. 10.1093/eurheartj/ehac488
- By:
- Publication type:
- Article
'Normal weight' is really not normal in chronic disease.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Empagliflozin in acute myocardial infarction: the EMMY trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4421, doi. 10.1093/eurheartj/ehac494
- By:
- Publication type:
- Article
Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4433, doi. 10.1093/eurheartj/ehac483
- By:
- Publication type:
- Article
promise and pitfalls of novel cuffless blood pressure devices.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4222, doi. 10.1093/eurheartj/ehac474
- By:
- Publication type:
- Article
Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4378, doi. 10.1093/eurheartj/ehac472
- By:
- Publication type:
- Article
Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
- Published in:
- 2022
- Publication type:
- Correction Notice
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4406, doi. 10.1093/eurheartj/ehac481
- By:
- Publication type:
- Article
Empagliflozin in patients hospitalized for acute heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4219, doi. 10.1093/eurheartj/ehac427
- By:
- Publication type:
- Article
Erratum to: Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
- Published in:
- 2022
- Publication type:
- Correction Notice
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4362, doi. 10.1093/eurheartj/ehac401
- By:
- Publication type:
- Article
Resounding victory in golf of the Continental Europe Team of Cardiology.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4224, doi. 10.1093/eurheartj/ehac392
- By:
- Publication type:
- Article
Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4374, doi. 10.1093/eurheartj/ehac399
- By:
- Publication type:
- Article
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4229, doi. 10.1093/eurheartj/ehac244
- By:
- Publication type:
- Article
case of bilateral atrial myxoma straddling the foramen ovale.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4440, doi. 10.1093/eurheartj/ehac386
- By:
- Publication type:
- Article
Making decision about fluid intake: increase or not increase.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Hypernatremia and subclinical chronic kidney disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4436, doi. 10.1093/eurheartj/ehac367
- By:
- Publication type:
- Article